📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Navin Fluorine Q3 FY26 PAT Jumps 122% to ₹185 Cr; Revenue Up 47% YoY
Navin Fluorine reported a stellar Q3 FY26 performance with revenue growing 47% YoY to ₹892 crores, driven by strong growth across all business verticals. The company's EBITDA margins expanded significantly to 34.5%, up from 24.3% in the previous year, reflecting strong operating leverage and better realizations. Notably, the Specialty Chemicals segment achieved its highest-ever quarterly revenue of ₹354 crores, while the CDMO business grew by 61% YoY. With the successful commissioning of Wave-1 CAPEX projects and a healthy pipeline for Wave-2, the company remains well-positioned for sustainable growth.
Key Highlights
Consolidated Revenue for Q3 FY26 rose 47% YoY to ₹892 crores, surpassing full-year FY25 revenue within nine months.
Net Profit (PAT) surged 122% YoY to ₹185 crores, with EBITDA margins expanding by 1,020 bps to 34.5%.
Specialty Chemicals vertical recorded its highest-ever quarterly revenue of ₹354 crores, a 60% YoY increase.
Successfully commissioned cGMP-4 Phase-1 and AHF projects, marking the completion of Wave-1 CAPEX.
Maintained a strong balance sheet with a net debt-to-equity ratio of 0.03x and working capital below 80 days.
💼 Action for Investors
Investors should view this as a strong growth signal given the massive margin expansion and successful execution of CAPEX projects. The stock remains a high-conviction play in the specialty fluorochemicals and CDMO space with clear revenue visibility.
Navin Fluorine Q3FY26: Revenue up 47% YoY to ₹892 Cr, EBITDA jumps 109%
Navin Fluorine reported a robust Q3FY26 with consolidated revenue growing 47% YoY to ₹892.4 crore. Operating EBITDA saw a significant surge of 109% YoY to ₹307.6 crore, with margins expanding by 1017 bps to 34.5%. Growth was driven by strong performance across Specialty Chemicals (+60% YoY), CDMO (+61% YoY), and HPP (+35% YoY) segments. The company is also progressing on several capex projects, including HFC expansion and MPP de-bottlenecking, aimed at future growth.
Key Highlights
Consolidated Revenue for Q3FY26 grew 47% YoY to ₹892.4 crore and 18% Q-o-Q.
Operating EBITDA margin expanded significantly to 34.5%, up from 24.3% in the previous year.
Specialty Chemicals revenue reached its highest-ever quarter at ₹354 crore, up 60% YoY.
CDMO business grew 61% YoY to ₹127 crore with strong order visibility for CY26 and beyond.
Announced ₹236.5 crore capex for additional HFC capacity (R32) with a peak revenue potential of ₹600-825 crore.
💼 Action for Investors
Investors should note the significant margin expansion and strong performance across all three business verticals. The stock remains a key play in the fluorination space with visible growth from upcoming capex in HFC and Specialty Chemicals.
Navin Fluorine Q3FY26: Revenue Jumps 47% to ₹892 Cr, EBITDA Surges 109% with Strong Margins
Navin Fluorine reported a robust Q3FY26 performance with consolidated revenue growing 47% YoY to ₹892.4 crore and Operating EBITDA surging 109% YoY to ₹307.6 crore. Operating EBITDA margins expanded significantly by 1017 bps YoY to 34.5%, driven by higher realizations and volumes across Specialty and HPP segments. The company is executing major capex projects, including a ₹236.5 crore HFC expansion and a ₹75 crore de-bottlenecking project, both targeted for Q3FY27. The CDMO business also showed strong momentum with 61% YoY growth and a positive outlook for CY26.
Key Highlights
Consolidated Q3FY26 Revenue grew 47% YoY to ₹892.4 Cr; Operating EBITDA rose 109% to ₹307.6 Cr.
Operating EBITDA margin reached 34.5%, up 1017 bps YoY and 201 bps Q-o-Q.
Specialty Chemicals segment achieved its highest-ever quarterly revenue of ₹354 Cr, up 60% YoY.
New HFC capacity capex of ₹236.5 Cr is on track for Q3FY27 with a peak revenue potential of ₹600-825 Cr.
CDMO segment revenue increased 61% YoY to ₹127 Cr with strong order visibility from European majors.
💼 Action for Investors
Investors should take note of the significant margin expansion and the aggressive capex roadmap which provides high revenue visibility through FY27. The stock remains a strong candidate for long-term portfolios focused on the specialty chemicals and CDMO sectors.
Navin Fluorine Q3 FY26: Revenue up 47% YoY to ₹892 Cr, EBITDA Margins Expand to 34.5%
Navin Fluorine reported a robust Q3 FY26 with consolidated revenue growing 47% YoY to ₹892.4 crore, driven by strong performance across all business verticals. Operating EBITDA surged 109% YoY to ₹307.6 crore, with margins expanding significantly by 1017 bps to 34.5%. The Specialty Chemicals segment achieved its highest-ever quarterly revenue of ₹354 crore, while the CDMO and HPP segments grew by 61% and 35% respectively. The company is aggressively investing in capex, including a ₹236.5 crore HFC expansion and ₹75 crore MPP de-bottlenecking, both targeted for Q3 FY27.
Key Highlights
Consolidated Revenue grew 47% YoY to ₹892.4 Cr; PAT increased 122% YoY to ₹185.4 Cr.
Operating EBITDA margin expanded significantly to 34.5% from 24.3% in the previous year.
Specialty Chemicals segment recorded its highest-ever quarterly revenue of ₹354 Cr, up 60% YoY.
CDMO business showed strong momentum with 61% YoY growth and robust order visibility for Q4 and beyond.
Announced HFC (R32) capex of ₹236.5 Cr with a peak revenue potential of ₹600-825 Cr per annum.
💼 Action for Investors
Investors should consider this a strong performance update, highlighting successful execution in high-margin segments and clear visibility for future growth through massive capex. The significant margin expansion and 'highest-ever' specialty revenue suggest a structural improvement in profitability.
Navin Fluorine Q3 FY26 Consolidated PAT Jumps 122% YoY to ₹185 Cr; Revenue Up 47%
Navin Fluorine reported a robust performance for Q3 FY26, with consolidated revenue growing 47.2% YoY to ₹892.37 crore. Net profit (PAT) surged by 121.7% YoY to ₹185.40 crore, even after accounting for an exceptional charge of ₹20.47 crore related to new labour code liabilities. The company demonstrated strong sequential momentum, with revenue and PAT increasing 17.6% and 24.9% respectively over Q2 FY26. Additionally, the company confirmed that the ₹750 crore raised via QIP in July 2025 has been fully utilized.
Key Highlights
Consolidated Revenue from operations grew 47.2% YoY to ₹892.37 crore from ₹606.20 crore.
Consolidated Profit After Tax (PAT) increased 121.7% YoY to ₹185.40 crore.
Recognized an exceptional item of ₹20.47 crore as incremental liability for employee benefits under New Labour Codes.
Basic EPS rose significantly to ₹36.18 from ₹16.86 in the corresponding quarter last year.
Interim dividend of ₹6.50 per share (325%) was paid during the quarter for FY 2025-26.
💼 Action for Investors
The strong top-line and bottom-line growth suggests successful capacity utilization and robust demand in the specialty chemicals segment. Investors should remain positive but monitor the long-term impact of the New Labour Codes on operating margins.
Navin Fluorine Q3 PAT surges 122% YoY to ₹185.4 Cr; Revenue up 47%
Navin Fluorine reported a strong performance for Q3 FY26, with consolidated revenue from operations growing 47.2% YoY to ₹892.37 crore. Net profit surged by 121.7% YoY to ₹185.40 crore, despite an exceptional charge of ₹20.47 crore related to new labour code compliance. The company maintained its growth momentum with a 17.6% QoQ increase in revenue and a 25% QoQ increase in PAT. Notably, nine-month revenue has already exceeded the total revenue for the previous full financial year.
Key Highlights
Consolidated Revenue from Operations grew 47.2% YoY to ₹892.37 crore in Q3 FY26.
Consolidated PAT increased by 121.7% YoY to ₹185.40 crore, with EPS rising to ₹36.18 from ₹16.86.
Reported an exceptional loss of ₹20.47 crore due to incremental liability from New Labour Codes.
9M FY26 revenue reached ₹2,376.19 crore, surpassing the full FY25 revenue of ₹2,349.38 crore.
The company paid an interim dividend of ₹6.50 per share (325% on face value) during the quarter.
💼 Action for Investors
Investors should maintain a positive outlook as the company demonstrates strong operational leverage and significant growth in its core chemical business. The robust 9M performance and successful utilization of QIP funds indicate a strong growth trajectory for the full year.
Navin Fluorine Commences Commercial Production of 40,000 TPA AHF Plant at Dahej
Navin Fluorine International Limited has successfully commissioned its new Anhydrous Hydrofluoric Acid (AHF) manufacturing plant at Dahej as of February 06, 2026. The facility has a significant production capacity of 40,000 tonnes per annum, which was built with a capital expenditure of ₹450 crores. This project, originally announced in March 2023, is now fully operational and entering the commercial production phase. This expansion is expected to enhance the company's backward integration capabilities and support its specialty chemicals business.
Key Highlights
Commenced commercial production of a new 40,000 tonnes per annum hydrofluoric acid capacity
Total capital expenditure for the project amounted to ₹450 crores
Facility is located at the Navin Fluorine Advanced Sciences Limited site in Dahej
Successful commissioning follows the initial investment announcement made on March 17, 2023
💼 Action for Investors
Investors should view this as a positive growth catalyst that strengthens the company's supply chain and margin profile. Monitor the utilization rates of this new capacity in upcoming quarterly reports to gauge revenue impact.
Navin Fluorine Q2 FY26 PAT Jumps 152% YoY to ₹148 Cr; EBITDA Margins Expand to 32.5%
Navin Fluorine reported a robust Q2 FY26 with consolidated revenue growing 46% YoY to ₹758.4 crore, driven by strong performance across CDMO (+98%) and Specialty Chemicals (+39%). Operating EBITDA surged 129% YoY to ₹246.2 crore, with margins expanding significantly by 1176 bps to 32.5%. The company also announced new capex of ₹236.5 crore for HFC capacity and ₹75 crore for MPP de-bottlenecking, targeting a combined peak revenue potential of nearly ₹1,000 crore per annum.
Key Highlights
Consolidated Net Revenue for Q2 FY26 rose 46% YoY to ₹758.4 crore, while H1 FY26 revenue grew 42% to ₹1,483.8 crore.
CDMO business vertical showed the highest growth, nearly doubling (+98%) to ₹134 crore in Q2 FY26.
Operating EBITDA margins improved sharply to 32.5% in Q2 FY26 from 20.7% in the same quarter last year.
Announced ₹236.5 crore capex for R32 HFC capacity with a peak revenue potential of ₹600-825 crore per annum.
Net Profit (PAT) for the quarter stood at ₹148.37 crore, representing a 152% increase over Q2 FY25.
💼 Action for Investors
The strong margin recovery and aggressive capex plans indicate a positive growth trajectory; investors should monitor the timely commissioning of the R32 and MPP projects by Q3 FY27.
Navin Fluorine Shareholders Approve Kartikeya Dube as Independent Director with 99.96% Majority
Navin Fluorine International Limited has announced the successful passage of a special resolution to appoint Mr. Kartikeya Dube as an Independent Director. The resolution was approved via a postal ballot process with an overwhelming 99.96% of votes cast in favor. Mr. Dube, who is the Chairman of bp Group of Companies in India, brings over 30 years of experience in finance, M&A, and the energy sector. This appointment, effective from December 3, 2025, is expected to strengthen the company's board governance and strategic oversight.
Key Highlights
Special resolution for the appointment of Mr. Kartikeya Dube passed with 99.9575% votes in favor.
A total of 37,787,936 valid votes were polled during the remote e-voting period ending January 28, 2026.
Mr. Dube brings 30+ years of experience and currently serves as Chairman of bp Group of Companies, India.
The appointment is for a fixed term and the director is not liable to retire by rotation.
Only 0.0425% of the total votes (16,055 votes) were cast against the resolution.
💼 Action for Investors
Investors should view this as a positive governance move that adds significant industrial and financial expertise to the board. No immediate trading action is required as this is a routine but high-quality management reinforcement.
Navin Fluorine Commences Commercial Production at Phase 1 of cGMP-4 Plant in Dewas
Navin Fluorine International Limited has officially commenced commercial production at Phase 1 of its cGMP-4 facility in Dewas as of December 31, 2025. This milestone follows the successful validation of batches by a European partner, ensuring the facility meets international quality standards. The project, which has been under development since early 2024, marks a significant transition from capital expenditure to revenue generation. This expansion is strategically aimed at strengthening the company's high-margin Contract Research and Manufacturing Services (CRAMS) vertical.
Key Highlights
Commencement of commercial operations at Phase 1 of the cGMP-4 plant in Dewas.
Successful validation of product batches by an unnamed European partner.
Project execution follows previous regulatory updates from February 2024 and September 2025.
Facility is expected to significantly contribute to the company's CRAMS business revenue.
💼 Action for Investors
Investors should monitor the revenue ramp-up from this facility in the coming quarters and look for updates regarding the commencement of Phase 2. The successful validation by a European partner is a strong indicator of the company's execution capabilities in the specialty chemicals space.
Navin Fluorine Proposes Appointment of Kartikeya Dube as Independent Director for 5-Year Term
Navin Fluorine International Limited has issued a postal ballot notice to seek shareholder approval for the appointment of Mr. Kartikeya Dube as an Independent Director. Mr. Dube, who is currently the Chairman of bp Group of Companies in India, is proposed for a five-year term effective from December 3, 2025, through December 2, 2030. The electronic voting period for shareholders is set to run from December 30, 2025, to January 28, 2026. This move aims to leverage Mr. Dube's 30-plus years of experience in finance, M&A, and the energy sector to strengthen the company's strategic oversight.
Key Highlights
Proposed appointment of Mr. Kartikeya Dube as Independent Director for a 5-year term ending December 2, 2030.
Mr. Dube brings over 30 years of experience, currently serving as Chairman of bp Group of Companies, India, and former CFO of Jio-bp.
Shareholder voting via electronic postal ballot is scheduled from December 30, 2025, to January 28, 2026.
The appointment requires a Special Resolution from the members of the company.
Mr. Dube's expertise spans strategic planning, finance, risk management, and M&A across global energy value chains.
💼 Action for Investors
Investors should view this as a positive governance development that adds significant industrial and financial expertise to the board. Shareholders are encouraged to participate in the e-voting process before the January 28, 2026 deadline.